These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 11365782

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Whitcup SM.
    JAMA; 2000 Feb 02; 283(5):653-7. PubMed ID: 10665706
    [Abstract] [Full Text] [Related]

  • 4. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR.
    J Infect Dis; 1998 May 02; 177(5):1182-7. PubMed ID: 9593001
    [Abstract] [Full Text] [Related]

  • 5. Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy.
    Di Perri G, Vento S, Mazzi R, Bonora S, Bonora A, Trevenzoli M, Allegranzi B, Carretta G, Lanzafame M, Pizzighella S, Concia E.
    J Infect; 1999 Nov 02; 39(3):193-7. PubMed ID: 10714794
    [Abstract] [Full Text] [Related]

  • 6. Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.
    Verbraak FD, Boom R, Wertheim-van Dillen PM, van den Horn GJ, Kijlstra A, de Smet MD.
    Br J Ophthalmol; 1999 Oct 02; 83(10):1186-9. PubMed ID: 10502584
    [Abstract] [Full Text] [Related]

  • 7. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR, Baldassano VF, Whitcup SM.
    Ophthalmology; 1998 Jul 02; 105(7):1259-64. PubMed ID: 9663231
    [Abstract] [Full Text] [Related]

  • 8. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy.
    Torriani FJ, Freeman WR, Macdonald JC, Karavellas MP, Durand DM, Jeffrey DD, Meylan PR, Schrier RD.
    AIDS; 2000 Jan 28; 14(2):173-80. PubMed ID: 10708288
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy.
    Berenguer J, González J, Pulido F, Padilla B, Casado JL, Rubio R, Arribas JR, Madrid Group for the Study of Discontinuation of Secondary Prophylaxis in Patients with CMV Retinitis.
    Clin Infect Dis; 2002 Feb 01; 34(3):394-7. PubMed ID: 11753827
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
    Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C, RESTIMOP study team.
    AIDS; 2001 Jan 05; 15(1):23-31. PubMed ID: 11192865
    [Abstract] [Full Text] [Related]

  • 13. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug 05; 12(8):92-4. PubMed ID: 11364475
    [Abstract] [Full Text] [Related]

  • 14. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
    Mowatt L.
    West Indian Med J; 2013 Aug 05; 62(4):305-12. PubMed ID: 24756590
    [Abstract] [Full Text] [Related]

  • 15. Sustained cytomegalovirus-specific CD4+ T cell response associated with prevention of recurrence of cytomegalovirus retinitis without secondary prophylaxis after highly active antiretroviral therapy in patients with AIDS.
    Tanaka M, Yasuoka C, Genka I, Tachikawa N, Kikuchi Y, Teruya K, Yasuoka A, Hirabayashi Y, Kimura S, Oka S.
    AIDS Res Hum Retroviruses; 2001 Dec 10; 17(18):1749-56. PubMed ID: 11788026
    [Abstract] [Full Text] [Related]

  • 16. Control of cytomegalovirus retinitis after combination antiretroviral therapy.
    Ruhswurm I, Ries E, Krepler K, Derbolav A, Rieger A, Armbruster C, Wedrich A.
    Acta Ophthalmol Scand; 1999 Aug 10; 77(4):471-3. PubMed ID: 10463426
    [Abstract] [Full Text] [Related]

  • 17. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV, Feinberg J, Hutchins RK, Frame RD, Schmidt DK, Viswanathan MN, Lalezari JP, McCune JM.
    J Infect Dis; 2001 Apr 15; 183(8):1285-9. PubMed ID: 11262214
    [Abstract] [Full Text] [Related]

  • 18. A prospective multicentre study of discontinuing prophylaxis for opportunistic infections after effective antiretroviral therapy.
    Green H, Hay P, Dunn DT, McCormack S, STOPIT Investigators.
    HIV Med; 2004 Jul 15; 5(4):278-83. PubMed ID: 15236617
    [Abstract] [Full Text] [Related]

  • 19. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.
    Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2004 Dec 15; 111(12):2232-9. PubMed ID: 15582079
    [Abstract] [Full Text] [Related]

  • 20. Cessation of anti-CMV therapy in patients with CMV retinitis.
    Dunn JP.
    Hopkins HIV Rep; 1998 Mar 15; 10(2):11. PubMed ID: 11365137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.